Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Early diagnosis and treatment can help manage fibrosing alopecia in older women.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Alopecia areata is significantly linked to thyroid issues and may worsen with diabetes severity.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia areata affects hair follicle structure, even in non-balding areas.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Prednisolone treatment improved symptoms and hair regrowth in a patient with Cronkhite-Canada Syndrome.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

New treatments for hair loss are available.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

PPX causes much less hair loss than traditional taxanes.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

Platelet-rich plasma boosts hair growth by enhancing autophagy.

Epidermal growth factor helps hair regrow after chemotherapy.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.